Objectives

Following the encouraging result of several registries and trials, very limited data exist on TAVI in the setting of a preexisting mitral prosthesis regarding the technique, potential complications, and outcomes. Therefore, we aimed to report our single centre experience with the implantation of the self-expandable CoreValve (Medtronic Inc., Minneapolis MN, USA) bioprostheticaortic valve in six patients with severe aortic stenosis.

Methods

This retrospective, observational study involved the period between February 2013 and December 2015, and all patients had previous mitral valve surgery in whom transfemoral TAVI has been performed at our center.

Methods

This retrospective, observational study involved the period between February 2013 and December 2015, and all patients had previous mitral valve surgery in whom transfemoral TAVI has been performed at our center.

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. OP-011 The Relationship Between Pulmonary Artery Stiffness and Functional Capacity in Patients With Heart Failure
2. OP-052 Antithrombotic Management in Patients with Atrial Fibrillation and High Risk of Stroke: Results from RAMSES Study
3. OP-087 Short- And Long-Term Effect of Simvastatin Therapy on the Heterogeneity of Cardiac Repolarization in Diabetic Patients
4. PP-026 Evaluation of Characteristics of Patients Hospitalized from the Emergency Service to Cardiology Service

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree